Xcout Intel
Telesis Bio Inc.
Telesis Bio Inc. is headquartered in San Diego, California, providing tools and support such as BioXP for synthetic biology.
Subscribe to see Telesis Bio Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Telesis Bio Inc. at a glance
Telesis Bio Inc. is a discovery tools company headquartered in United States. It has raised at least $53M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round raised $28M in June 2023. Xcout tracks 10 named people at Telesis Bio Inc., including Eric Esser (President, Chief Executive Officer + Chairman of the Board of Directors).
Telesis Bio Inc. leadership
- Eric EsserPresident, Chief Executive Officer + Chairman of the Board of Directors
- Daniel G. Gibson, PhDChief Technology Officer
- Krishna Kannan, PhD, MBAVP, Product and Operations
- Rocky McDonald, CPASenior VP, Finance
- Todd KruegerCEO & President, AOB Pharma
- Sarah HlavinkaExecutive Vice President, The ODP Corporation
4 more named people on record for Telesis Bio Inc., with roles, board committees and tenure — see the full roster →
Telesis Bio Inc. funding rounds
At least $53M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $28M | — | |
| Growth | $28M | 1 named | |
| Series A | Undisclosed | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Telesis Bio Inc. competitors
A few of Telesis Bio Inc.'s closest competitors — see the full list of competitors and alternatives →
Debut Biotech is a synthetic biology and biotechnology company headquartered in San Diego, California. The company utilizes advanced science and technology platforms to manufacture sustainable ingredients and products through biomanufacturing.
Syntax Bio is a biotechnology research company headquartered in Chicago, Illinois, focused on synthetic biology. The company utilizes its proprietary Cellgorithm CRISPR-based platform to program stem cells and accelerate the development of next-generation organoids and cell-derived therapies.
Synthego Holdings LLC is a biotechnology and CRISPR solutions company headquartered in Redwood City, California. It delivers cutting-edge molecular diagnostics and tools designed to accelerate life science research and development for improved human health.
Algenesis Materials is a sustainable materials science company based in San Diego, California, recognized for developing eco-friendly polymer alternatives and green chemistry solutions.
Growth Curve Bio provides full-stack synthetic biology services, including strain engineering, rapid prototyping, process optimization, pilot-scale production, and manufacturing hand-off. The company serves synthetic biology teams and organizations looking to develop and scale bioproducts from engineered cells.
Get Telesis Bio Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Telesis Bio Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access